Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results

Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by $2.15, Revenues Rise 3400%; Raises Outlook

March 4, 2021 4:15 PM EST

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of $6.20, $2.15 better than the analyst estimate of $4.05. Revenue for the quarter came in at $295 million versus the consensus estimate of $199.44 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2021 EPS of $12.50, versus the consensus of $11.55. Fulgent Genetics, Inc. sees FY2021 revenue of $800 million, versus the consensus of $600.24 million.

Ming Hsieh, Chairman and Chief Executive Officer, said, Our record fourth quarter results capped off a transformational year for Fulgent Genetics. While we did not envision 2020 to unfold in... More